TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/3/23 18:34 | 3/2/23 | NUS | Nu Skin Enterprises, Inc. | DE | Retail | WhDrg | Drugs, Proprietaries & Druggi | Lawrence Mark H | UT | O | CFO | M.d | 549 | 30.45 | 0 | 18 | 46 | 57 | D | ||||||||||||||
3/3/23 18:34 | 3/2/23 | NUS | Nu Skin Enterprises, Inc. | DE | Retail | WhDrg | Drugs, Proprietaries & Druggi | Lawrence Mark H | UT | O | CFO | S.d | -1,067 | 40.80 | 0 | -26 | -31 | 57 | D | ||||||||||||||
6/8/22 18:08 | 6/6/22 | NUS | Nu Skin Enterprises, Inc. | DE | Retail | WhDrg | Drugs, Proprietaries & Druggi | Lawrence Mark H | UT | O | CFO | S | -276 | 47.03 | 0 | -6 | -11 | 48 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |